Katarı́na Rašlová

3.7k citations

46 papers · 1.6k indexed · 1 hit paper · h-index 17

Cancer Research top 5%
- Cancer, Lipids, and Metabolism 8
- Carcinogens and Genotoxicity Assessment 3
Endocrinology, Diabetes and Metabolism top 5%
- Diabetes, Cardiovascular Risks, and Lipoproteins 11
- Diabetes Management and Research 6
- Diabetes Treatment and Management 4
Biochemistry top 5%
- Antioxidant Activity and Oxidative Stress 9
Health, Toxicology and Mutagenesis top 5%
Chemical Health and Safety top 10%
Surgery
- Lipoproteins and Cardiovascular Health 17
Rheumatology
- Folate and B Vitamins Research 5

Co-authors: Mária Dušinská Andrew Collins Helena Petrovská Martina Somorovská Nicholas J. Vaughan Mihalis I. Panayiotidis Susan J. Duthie Michael Franklin
Cited by: Cancer Research Endocrinology, Diabetes and Metabolism Biochemistry
Journals: PLoS ONE (1 paper)Free Radical Biology and Medicine (1 paper)Food and Chemical Toxicology (1 paper)
Partner nations: Slovakia Czechia United Kingdom

In The Last Decade

Katarı́na Rašlová

45 papers receiving 1.5k citations

Hit Papers

align trajectories log scale

Peers

Countries citing papers authored by Katarı́na Rašlová

Since Specialization

Citations

This map shows the geographic impact of Katarı́na Rašlová's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Katarı́na Rašlová with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Katarı́na Rašlová more than expected).

Fields of papers citing papers by Katarı́na Rašlová

Since Specialization

Physical SciencesHealth SciencesLife SciencesSocial Sciences

This network shows the impact of papers produced by Katarı́na Rašlová. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Katarı́na Rašlová. The network helps show where Katarı́na Rašlová may publish in the future.

Co-authorship network

The 25 scholars most cited alongside Katarı́na Rašlová, linked wherever they have co-authored with each other. Click a name or a connecting line to browse the papers they share.

Border = papers with Katarı́na Rašlová Line = papers co-authored together Katarı́na Rašlová links everyone, so they are left out of the graph.

All Works

Sort: Min cites: Since: Top N: Style:

20 of 20 papers shown

#	Work
1	Effect of insulin degludec versus insulin glargine U100 on time in range: SWITCH PRO , a crossover study of basal insulin‐treated adults with type 2 diabetes and risk factors for hypoglycaemia Diabetes Obesity and Metabolism ·Ronald Goldenberg,Vanita R. Aroda,Liana K. Billings,A. Sia Louise Christiansen,Anders Meller Donatsky,Ehsan Parvaresh Rizi,Gracjan Podgorski,Katarı́na Rašlová,David C. Klonoff,Richard M. Bergenstal	2021	18
2	Lipid-lowering therapy use in primary and secondary care in Central and Eastern Europe: DA VINCI observational study Atherosclerosis ·Michal Vráblík,Bohumil Seifert,Alexander Parkhomenko,Maciej Banach,Jacek Jerzy Jozwiak,Róbert Gábor Kiss,Dan Gaiță,Katarı́na Rašlová,Marie Zachlederova,Sarah Bray,Kausik K. Ray	2021	42
3	The Impact of the International Cooperation On Familial Hypercholesterolemia Screening and Treatment: Results from the ScreenPro FH Project Current Atherosclerosis Reports ·R Češka,Gustavs Latkovskis,М. В. Ежов,Tomáš Freiberger,Katarina Lalić,Olena Mitchenko,György Paragh,Žaneta Petrulionienė,Belma Pojskić,Katarı́na Rašlová,Aleksandr B. Shek,Branislav Vohnout,Tereza Altschmiedová,Veronika Todorovová	2019	10
4	Therapeutic plasma exchange in secondary prevention of acute pancreatitis in pregnant patient with familial hyperchylomicronemia Biomedical Papers ·Renáta Michalová,A.A. Mańkova,Matej Vnučák,Stanislava Mikulova,František Neháj,Katarı́na Rašlová,Ivana Dedinská,A Jezíková,Pavel Makovický,Péter Galajda,Marián Mokáň	2018	7
5	Real-life LDL-C treatment goals achievement in patients with heterozygous familial hypercholesterolemia in the Czech Republic and Slovakia: Results of the PLANET registry Atherosclerosis ·Michal Vráblík,Katarı́na Rašlová,Branislav Vohnout,V. Bláha,(unknown),Ondřej Kyselák,Martina Vaclová,Robin Urbánek,Jana Mašková,Vladimír Soška,Tomáš Freiberger	2018	18
6	[Diabetes and dyslipidemia: Why are they so closely related?] PubMed ·Katarı́na Rašlová	2017	7
7	The Molecular Genetic Background of Familial Hypercholesterolemia: Data From the Slovak Nation-Wide Survey Physiological Research ·Dominika Gabcova,Branislav Vohnout,Daniela Staníková,Miroslava Hučková,Michaela Kadurová,Marianna Debreová,Miriam Kozárová,Ľubomíra Fábryová,SLOVAK FH STUDY GROUP,Juraj Staník,I Klimeś,Katarı́na Rašlová,Daniela Gašperíková	2017	6
8	Genetic testing of familial hypercholesterolemia in a real clinical setting Wiener klinische Wochenschrift ·Branislav Vohnout,Dominika Gabcova,Miroslava Hučková,I Klimeś,Daniela Gašperíková,Katarı́na Rašlová	2016	7
9	An update on the treatment of type 1 and type 2 diabetes mellitus: focus on insulin detemir, a long-acting human insulin analog Vascular Health and Risk Management ·Katarı́na Rašlová	2010	24
10	Apolipoprotein E polymorphism in relation to plasma lipid levels and other risk factors of atherosclerosis in two ethnic groups from Slovakia. PubMed ·Daniela Siváková,Mária Zacharová,Juraj Gašparovič,Katarı́na Rašlová,Ladislava Wsólová,Zuzana Bašistová,(unknown)	2006	6
11	Seasonal changes in markers of oxidative damage to lipids and DNA; correlations with seasonal variation in diet Mutation research. Fundamental and molecular mechanisms of mutagenesis ·Božena Smolková,Mária Dušinská,Katarı́na Rašlová,Geraldine McNeill,Viera Spustová,P Blažı́ček,Alexandra Horská,Andrew Collins	2004	45
12	Effect of C677T methylenetetrahydrofolate reductase gene polymorphism on plasma homocysteine levels in ethnic groups. Physiological Research ·Juraj Gašparovič,Katarı́na Rašlová,Zuzana Bašistová,Mária Zacharová,Ladislava Wsólová,Mária Avdičová,P Blažı́ček,J. Lietava,Daniela Siváková	2004	12
13	DNA damage and antioxidants; fluctuations through the year in a central European population group Food and Chemical Toxicology ·Mária Dušinská,Bibiana Vallová,Monika Ursı́nyová,V. Hladíková,Božena Smolková,Ladislava Wsólová,Katarı́na Rašlová,Andrew Collins	2002	51
14	Atherogenic lipoprotein profile in families with and without history of early myocardial infarction Physiological Research ·M Dobiášová,Katarı́na Rašlová,Hana Rauchová,Branislav Vohnout,K. Ptáčková,J. Frohlich	2001	22
15	Risk factors for atherosclerosis in survivors of myocardial infarction and their spouses: Comparison to controls without personal and family history of atherosclerosis Metabolism ·Katarı́na Rašlová,Božena Smolková,Branislav Vohnout,Juraj Gašparovič,Jiří Fröhlich	2001	17
16	Effect of ciprofibrate on lipoprotein metabolism and oxidative stress parameters in patients with type 2 diabetes mellitus and atherogenic lipoprotein phenotype Acta Diabetologica ·Katarı́na Rašlová,A Nagyová,M Dobiášová,K. Ptáčková,Mária Dušinská	2000	10
17	Serum Lipid Resistance to Oxidation and Uric Acid Levels in Subjects with Down's s Syndrome Physiological Research ·A Nagyová,M Šustrová,Katarı́na Rašlová	2000	13
18	DNA Damage in Diabetes: Correlation with a Clinical Marker Free Radical Biology and Medicine ·Andrew Collins,Katarı́na Rašlová,Martina Somorovská,Helena Petrovská,A Ondrusova,Branislav Vohnout,Radoslav Fábry,Mária Dušinská	1998	153
19	Apolipoprotein E genotypes in offspring with a positive and negative family history of premature myocardial infarction Clinical Genetics ·Katarı́na Rašlová,Božena Smolková,Branislav Vohnout,Branislav Schifferdecker,R. Poledne,Mária Dušinská	1998	7
20	Comet assay in human biomonitoring studies: Reliability, validation, and applicationsbreakdown → Environmental and Molecular Mutagenesis ·Andrew Collins,Mária Dušinská,Michael Franklin,Martina Somorovská,Helena Petrovská,Susan J. Duthie,Laurence Fillion,Mihalis I. Panayiotidis,Katarı́na Rašlová,Nicholas J. Vaughan	1997	561

About Katarı́na Rašlová

Katarı́na Rašlová is a scholar working on Biochemistry, Endocrinology, Diabetes and Metabolism and Cancer Research, having authored 46 papers that have together received 1.6k indexed citations. Recurring topics across this work include Lipoproteins and Cardiovascular Health (17 papers), Diabetes, Cardiovascular Risks, and Lipoproteins (11 papers), Antioxidant Activity and Oxidative Stress (9 papers), Cancer, Lipids, and Metabolism (8 papers), Diabetes Management and Research (6 papers), Folate and B Vitamins Research (5 papers), Diabetes Treatment and Management (4 papers) and Carcinogens and Genotoxicity Assessment (3 papers). The work is most often cited by research in Cancer Research (423 citations), Endocrinology, Diabetes and Metabolism (389 citations) and Biochemistry (124 citations). Katarı́na Rašlová has collaborated with scholars based in Slovakia, Czechia and United Kingdom. Frequent co-authors include Mária Dušinská, Andrew Collins, Helena Petrovská, Martina Somorovská, Nicholas J. Vaughan, Mihalis I. Panayiotidis, Susan J. Duthie, Michael Franklin, Branislav Vohnout and Itamar Raz. Their work appears in journals such as PLoS ONE, Free Radical Biology and Medicine and Food and Chemical Toxicology.

Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.

Explore authors with similar magnitude of impact